Selected research
Industry Research
Anti-Fungal Agents Industry Research Report 2026
Market perspective
The global Anti-Fungal Agents market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Anti-Fungal Agents is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Anti-Fungal Agents is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Anti-Fungal Agents is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Anti-Fungal Agents include Novartis, Merck, Pfizer, GlaxoSmithKline, Bayer, Valeant Pharmaceuticals International, Sanofi-Aventis, Enzon Pharmaceutical and Basilea Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Anti-Fungal Agents market in terms of revenue (US$ million) and, where applicable, sales volume (k tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Anti-Fungal Agents Market by Company
Novartis
Merck
Pfizer
GlaxoSmithKline
Bayer
Valeant Pharmaceuticals International
Sanofi-Aventis
Enzon Pharmaceutical
Basilea Pharmaceutical
Astellas Pharma
Agilent Technologies
Abbot
Anti-Fungal Agents Segment by Type
Azoles
Polyenes
5-fluorocytosine
Other
Anti-Fungal Agents Segment by Application
Hospital
Clinic
Other
Anti-Fungal Agents Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Fungal Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-Fungal Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Fungal Agents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Anti-Fungal Agents manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Anti-Fungal Agents by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Anti-Fungal Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Azoles
- Polyenes
- 5-fluorocytosine
- Other
Applications
- Hospital
- Clinic
- Other
Companies covered
- Novartis
- Merck
- Pfizer
- GlaxoSmithKline
- Bayer
- Valeant Pharmaceuticals International
- Sanofi-Aventis
- Enzon Pharmaceutical
- Basilea Pharmaceutical
- Astellas Pharma
- Agilent Technologies
- Abbot
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Anti-Fungal Agents Market Size (2021-2032)
- 2.2.2 Global Anti-Fungal Agents Sales (2021-2032)
- 2.2.3 Global Anti-Fungal Agents Market Average Price (2021-2032)
- 2.3 Anti-Fungal Agents by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Azoles
- 2.3.3 Polyenes
- 2.3.4 5-fluorocytosine
- 2.3.5 Other
- 2.4 Anti-Fungal Agents by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Anti-Fungal Agents Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Anti-Fungal Agents Sales (k tons) of Manufacturers (2021-2026)
- 3.3 Global Anti-Fungal Agents Revenue of Manufacturers (2021-2026)
- 3.4 Global Anti-Fungal Agents Average Price by Manufacturers (2021-2026)
- 3.5 Global Anti-Fungal Agents Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Anti-Fungal Agents, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Anti-Fungal Agents, Product Type & Application
- 3.8 Global Manufacturers of Anti-Fungal Agents, Established Date
- 3.9 Global Anti-Fungal Agents Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novartis
- 4.1.1 Novartis Company Information
- 4.1.2 Novartis Business Overview
- 4.1.3 Novartis Anti-Fungal Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novartis Anti-Fungal Agents Product Portfolio
- 4.1.5 Novartis Recent Developments
- 4.2 Merck
- 4.2.1 Merck Company Information
- 4.2.2 Merck Business Overview
- 4.2.3 Merck Anti-Fungal Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Merck Anti-Fungal Agents Product Portfolio
- 4.2.5 Merck Recent Developments
- 4.3 Pfizer
- 4.3.1 Pfizer Company Information
- 4.3.2 Pfizer Business Overview
- 4.3.3 Pfizer Anti-Fungal Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer Anti-Fungal Agents Product Portfolio
- 4.3.5 Pfizer Recent Developments
- 4.4 GlaxoSmithKline
- 4.4.1 GlaxoSmithKline Company Information
- 4.4.2 GlaxoSmithKline Business Overview
- 4.4.3 GlaxoSmithKline Anti-Fungal Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 GlaxoSmithKline Anti-Fungal Agents Product Portfolio
- 4.4.5 GlaxoSmithKline Recent Developments
- 4.5 Bayer
- 4.5.1 Bayer Company Information
- 4.5.2 Bayer Business Overview
- 4.5.3 Bayer Anti-Fungal Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Bayer Anti-Fungal Agents Product Portfolio
- 4.5.5 Bayer Recent Developments
- 4.6 Valeant Pharmaceuticals International
- 4.6.1 Valeant Pharmaceuticals International Company Information
- 4.6.2 Valeant Pharmaceuticals International Business Overview
- 4.6.3 Valeant Pharmaceuticals International Anti-Fungal Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Valeant Pharmaceuticals International Anti-Fungal Agents Product Portfolio
- 4.6.5 Valeant Pharmaceuticals International Recent Developments
- 4.7 Sanofi-Aventis
- 4.7.1 Sanofi-Aventis Company Information
- 4.7.2 Sanofi-Aventis Business Overview
- 4.7.3 Sanofi-Aventis Anti-Fungal Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Sanofi-Aventis Anti-Fungal Agents Product Portfolio
- 4.7.5 Sanofi-Aventis Recent Developments
- 4.8 Enzon Pharmaceutical
- 4.8.1 Enzon Pharmaceutical Company Information
- 4.8.2 Enzon Pharmaceutical Business Overview
- 4.8.3 Enzon Pharmaceutical Anti-Fungal Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Enzon Pharmaceutical Anti-Fungal Agents Product Portfolio
- 4.8.5 Enzon Pharmaceutical Recent Developments
- 4.9 Basilea Pharmaceutical
- 4.9.1 Basilea Pharmaceutical Company Information
- 4.9.2 Basilea Pharmaceutical Business Overview
- 4.9.3 Basilea Pharmaceutical Anti-Fungal Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Basilea Pharmaceutical Anti-Fungal Agents Product Portfolio
- 4.9.5 Basilea Pharmaceutical Recent Developments
- 4.10 Astellas Pharma
- 4.10.1 Astellas Pharma Company Information
- 4.10.2 Astellas Pharma Business Overview
- 4.10.3 Astellas Pharma Anti-Fungal Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Astellas Pharma Anti-Fungal Agents Product Portfolio
- 4.10.5 Astellas Pharma Recent Developments
- 4.11 Agilent Technologies
- 4.11.1 Agilent Technologies Company Information
- 4.11.2 Agilent Technologies Business Overview
- 4.11.3 Agilent Technologies Anti-Fungal Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Agilent Technologies Anti-Fungal Agents Product Portfolio
- 4.11.5 Agilent Technologies Recent Developments
- 4.12 Abbot
- 4.12.1 Abbot Company Information
- 4.12.2 Abbot Business Overview
- 4.12.3 Abbot Anti-Fungal Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Abbot Anti-Fungal Agents Product Portfolio
- 4.12.5 Abbot Recent Developments
5 Global Anti-Fungal Agents Market Scenario by Region
- 5.1 Global Anti-Fungal Agents Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Anti-Fungal Agents Sales by Region: 2021-2032
- 5.2.1 Global Anti-Fungal Agents Sales by Region: 2021-2026
- 5.2.2 Global Anti-Fungal Agents Sales by Region: 2027-2032
- 5.3 Global Anti-Fungal Agents Revenue by Region: 2021-2032
- 5.3.1 Global Anti-Fungal Agents Revenue by Region: 2021-2026
- 5.3.2 Global Anti-Fungal Agents Revenue by Region: 2027-2032
- 5.4 North America Anti-Fungal Agents Market Facts & Figures by Country
- 5.4.1 North America Anti-Fungal Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Anti-Fungal Agents Sales by Country (2021-2032)
- 5.4.3 North America Anti-Fungal Agents Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Anti-Fungal Agents Market Facts & Figures by Country
- 5.5.1 Europe Anti-Fungal Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Anti-Fungal Agents Sales by Country (2021-2032)
- 5.5.3 Europe Anti-Fungal Agents Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Anti-Fungal Agents Market Facts & Figures by Country
- 5.6.1 Asia Pacific Anti-Fungal Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Anti-Fungal Agents Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Anti-Fungal Agents Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Anti-Fungal Agents Market Facts & Figures by Country
- 5.7.1 South America Anti-Fungal Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Anti-Fungal Agents Sales by Country (2021-2032)
- 5.7.3 South America Anti-Fungal Agents Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Anti-Fungal Agents Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Anti-Fungal Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Anti-Fungal Agents Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Anti-Fungal Agents Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Anti-Fungal Agents Sales by Type (2021-2032)
- 6.1.1 Global Anti-Fungal Agents Sales by Type (2021-2032) & (k tons)
- 6.1.2 Global Anti-Fungal Agents Sales Market Share by Type (2021-2032)
- 6.2 Global Anti-Fungal Agents Revenue by Type (2021-2032)
- 6.2.1 Global Anti-Fungal Agents Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Anti-Fungal Agents Revenue Market Share by Type (2021-2032)
- 6.3 Global Anti-Fungal Agents Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Anti-Fungal Agents Sales by Application (2021-2032)
- 7.1.1 Global Anti-Fungal Agents Sales by Application (2021-2032) & (k tons)
- 7.1.2 Global Anti-Fungal Agents Sales Market Share by Application (2021-2032)
- 7.2 Global Anti-Fungal Agents Revenue by Application (2021-2032)
- 7.2.1 Global Anti-Fungal Agents Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Anti-Fungal Agents Revenue Market Share by Application (2021-2032)
- 7.3 Global Anti-Fungal Agents Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Anti-Fungal Agents Value Chain Analysis
- 8.1.1 Anti-Fungal Agents Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Anti-Fungal Agents Production Mode & Process
- 8.2 Anti-Fungal Agents Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Anti-Fungal Agents Distributors
- 8.2.3 Anti-Fungal Agents Customers
9 Global Anti-Fungal Agents Analyzing Market Dynamics
- 9.1 Anti-Fungal Agents Industry Trends
- 9.2 Anti-Fungal Agents Industry Drivers
- 9.3 Anti-Fungal Agents Industry Opportunities and Challenges
- 9.4 Anti-Fungal Agents Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst